Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
2(50.0%)
4Total
Phase 3(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06867705Phase 3Recruiting

Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only

Role: collaborator

NCT06050642Not ApplicableRecruiting

Study of the Impact of PROximity Support for Patients With Type 1 DIABetes Treated With an Insulin Pump or Closed Loop.

Role: collaborator

NCT07043036Phase 3Not Yet Recruiting

Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy

Role: collaborator

NCT06738849Not ApplicableRecruiting

EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation

Role: collaborator

NCT06997055Recruiting

ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar

Role: collaborator

NCT06089590Recruiting

Ibd CAncer and seRious Infections in France (I-CARE 2)

Role: collaborator

NCT04657783Recruiting

French National Cohort of People With Type 1 Diabetes

Role: collaborator

All 7 trials loaded